Tees, Esk and Wear Valleys NHS FT and Teesside Uni have co-developed an augmented reality mental health crisis simulation training app.

New analysis by Future Health Intelligence has found that the majority of NHS trusts still spend large sums to maintain paper medical records. 

In a remarkable twist of science, researchers have transformed a fungus long associated with death into a potential weapon against cancer. Found in tombs like that of King Tut, Aspergillus flavus was once feared for its deadly spores. Now, scientists at Penn and several partner institutions have extracted a new class of molecules from it—called asperigimycins—that show powerful effects against leukemia cells. These compounds, part of a rare group known as fungal RiPPs, were bioengineered for potency and appear to disrupt cancer cell division with high specificity.

Fresh concerns have emerged about the platelet studies underpinning the FDA approval of ticagrelor, AstraZeneca's multibillion-dollar heart drug. A new BMJ investigation reveals data discrepancies, missing lab readings, and questions about the integrity of the trial process. Notably, key results reported in a major cardiology journal were inaccurately presented, and some study contributors were omitted or denied involvement. With generics on the horizon, critics say these revelations highlight potential dangers, including severe rebound effects and bleeding risks, that were never properly disclosed.

As artificial intelligence evolves, how can we ensure transparency and accountability? Matt Wood, PwC's Global and US Commercial Technology & Innovation Officer, discusses the challenges and opportunities of building confidence in agentic AI.